Description
The less active enantiomer of (–)-nutlin-3; inhibits the interaction between p53 and Mdm2 150-fold less potently than (–)-nutlin-3 (IC50 = 13.6 µM); has been used as a negative control for the p53-modulating activity of (–)-nutlin-3 in cancer cells